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Available online xxxxBackground: Progression of Alzheimer's disease is thought initially to depend on rising amyloidβ and its synaptic
interactions. Transgenic mice (TASTPM; APPSwe/PSEN1M146V) show altered synaptic transmission, compatible
with increased physiological function of amyloidβ, before plaques are detected. Recently, the importance of
microglia has become apparent in the human disease. Similarly, TASTPM show a close association of plaque
load with upregulated microglial genes.
Methods: CA1 synaptic transmission and plasticity were investigated using in vitro electrophysiology. Microglial
relationship to plaques was examined with immunohistochemistry. Behaviour was assessed with a forced-
alternation T-maze, open ﬁeld, light/dark box and elevated plus maze.
Findings: Themost striking ﬁnding is the increase inmicroglial numbers in TASTPM,which, like synaptic changes,
begins before plaques are detected. Further increases and a reactive phenotype occur later, concurrent with de-
velopment of larger plaques. Long-term potentiation is initially enhanced at pre-plaque stages but decrements
with the initial appearance of plaques. Finally, despite altered plasticity, TASTPM have little cognitive deﬁcit,
even with a heavy plaque load, although they show altered non-cognitive behaviours.
Interpretation: The pre-plaque synaptic changes andmicroglial proliferation are presumably related to low, non-
toxic amyloidβ levels in the general neuropil and not directly associatedwith plaques. However, as plaques grow,
microglia proliferate further, clustering around plaques and becoming phagocytic. Like in humans, even when
plaque load is heavy, without development of neuroﬁbrillary tangles and neurodegeneration, these alterations
do not result in cognitive deﬁcits. Behaviours are seen that could be consistent with pre-diagnosis changes in
the human condition.
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The onset and progression of Alzheimer's disease (AD) is most likely
initiated by environmental factors interacting with predisposed genetic
risks, many of which have now been identiﬁed in genome-wide associ-
ation studies (see reference 1 for review). In familial AD, an inherited
mutation causes rising amyloidβ (Aβ) levels and it has long been
established that this triggers a chain of events that leads to the eventual
cognitive decline [2]. In sporadic AD, it is highly likely that initial trigger-
ing events (genetic and/or environmental) also lead to rising Aβ and
that, like in the familial disease, Aβ levels represent an essential contrib-
utor to the ongoing pathology and eventual neurodegeneration [3,4].-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Research in context
Evidence before this study
There is a large body of research examining many aspects of phe-
notypes associatedwithmousemodels of Alzheimer's disease – a
PubMed search for the terms Alzheimer* AND mouse returns in
excess of 21,000 articles. However, there are few systematic ar-
ticles pulling together pathological, functional (electrophysiologi-
cal), and behavioural analyses across the life-span of such
models. There is also a number of conflicting outcomes, for exam-
ple reports of impaired versus enhanced synaptic plasticity; cogni-
tive impairments or not.
Recently, the importance of microglia in Alzheimer's disease has
come to the fore in human genome-wide association studies
(GWAS), with variants of a number of microglial genes identified
as risk-factors for developing the disease. Interestingly, we have
recently reported that Trem2 and other genes identified as risk-
factors in humans are strongly up regulated in close association
to plaque development in the mouse model used in this study.
Moreover, this previous study predicted two of the most recently
identified genes that were identified in GWAS since the publica-
tion of our paper.
We have previously used this model to identify the earliest synap-
tic changes and shown changes in release of glutamate, the pri-
mary excitatory neurotransmitter in the brain, to occur even
before plaques are detectable.
Added value of this study
By studying this transgenic mouse model of Alzheimer's disease,
throughout the development of plaques, from prior to detection
through to heavy plaque loads, we have been able to identify a
clear time course of key phenotypic changes associated with
early disease. In particular, this study identifies the very early
changes in microglia and can separate the time course of the
microglial phenotype. In addition, we detail the changes in synap-
tic plasticity over time and importantly identify that, like in humans
in the absence of Tau tangles or neurodegeneration, considerable
synaptic changes and a heavy plaque load can occur without
resulting in substantial cognitive loss.
Implications of all the available evidence
Our data indicate that rising amyloidβ prior to detectable plaque
deposition results in changes in synaptic function that likely reflect
an enhanced physiological effect of amyloidβ. At this stage, mi-
croglia proliferate but do not activate. Once plaques begin to ap-
pear, microglia migrate to surround the plaque and become
phagocytic, likely targeting dystrophic synapses and neurites
caused by the cloud of highly-toxic amyloidβ around the plaque.
Similarly to humans, who have plaques but no tangles and have
yet to develop substantial neurodegeneration, cognitive deficits
are not seen, even with a heavy plaque load; behavioural changes
are limited to anxiety-like effects.
This investigation of the parallel time-course of events highlights
the probability that, if progression of disease can be reversed or
slowed early enough, before Tau tangles and substantial neurode-
generation occur, the symptomsof cognitive decline could be very
largely avoided. Moreover, it suggests that the substantial in-
creases in microglia number and upregulation of their specific
gene expression in association with plaques is not associated
with cognitive loss and may indeed be protective.
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dependent synaptic modulator which, when released from presynaptic
neuronal terminals, increases probability of glutamate release [5]. Inap-
propriate neuronal activity and/or genetic imbalances in production
versus clearance mechanisms may thus lead to a prolonged rise in Aβ
levels [6], enabling the formation of Aβ oligomers and deposition of
plaques. It is notable that restoring γ-frequency oscillations in trans-
genic mouse models expressing genes harbouring familial mutations
associated with familial AD, reduces Aβ load [7] and restores cognitive
deﬁcits [8].
Animal models for AD have generally depended on transgenic ex-
pression, or more recently knock-in of the gene variants that cause
the familial dominantly inherited forms of the disease, particularly
amyloid precursor protein (APP) or presenilin 1 or 2 (PSEN1 or
PSEN2). This is an effective approach for initiating the rise in Aβ and
the deposition of plaques, albeit by a different trigger than in sporadic
AD. According to the ‘amyloid hypothesis’, in the human disease, a rise
in Aβ levels and plaque deposition is suggested to lead to altered neu-
ronal ionic homeostasis and increased oxidative stress. Together, these
may result in increased kinase activity on microtubule-associated pro-
tein Tau, resulting in Tau hyperphosphorylation and neuroﬁbrillary
tangle formation [9]. The exact mechanisms linking Aβ and Tau phos-
phorylation remain unclear and unfortunately, despite the initiation of
Aβ pathology, mouse models with genes for familial Alzheimer's dis-
ease do not completely recapitulate these later events. As documented
in the initial descriptions of the TASTPM mice, which are hemizygous
for both human APPSwe and human PSEN1M146V, plaques are ﬁrst de-
tected at approximately 4 months of age and a considerable plaque
load develops by 8 months [10,11]. Furthermore, phosphorylation
of Tau is detectable in the dystrophic neurites around plaques [11],
recently suggested to be an early stage of Tau pathology [12]. An
inability to extinguish hippocampal-dependent contextual fear condi-
tioning at 4 months when plaques are ﬁrst detected [13,14] and a def-
icit in novel object recognition at 6 months [15], have also been
reported.
We recently reported alterations in synaptic transmission preceding
the detection of plaques, manifesting as a loss of spontaneous action po-
tentials in Schaffer collateral axons and a concomitant increase in prob-
ability of glutamate release [16]. Importantly, we have demonstrated an
almost 1:1 correlation of plaque load with expression of a module of
microglial genes throughout the life of these and other transgenic
mice. This correlation in Αβmice contrasts with the interaction of mi-
croglia and neuroﬁbrillary tangles in mice with Tau mutations, in
which microglial genes are only upregulated with advanced tangle
load (www.mouseac.org) [10].
Herewe extendour previous studies on TASTPMmice to understand
the relationship between early changes in synaptic transmission, synap-
tic plasticity, cognitive function and microglia. We study the develop-
ment of plaques in more detail and dissect out the microglial response
to distinguish between the numbers of microglia and their phagocytic
status.We ﬁnd that, like synaptic changes,microglia aremore prevalent
even before plaques are detectable, whereas their phagocytic pheno-
type is age-related, coming much later. We then proceed to study hip-
pocampal synaptic plasticity and hippocampus-dependent learning, in
the forced-alternation T-maze, enabling identiﬁcation of Aβ pheno-
types, ﬁnding little cognitive deﬁcit even with a heavy plaque load but
clear behavioural changes, probably related to increased levels of
anxiety.
While we continue to focus mainly on the previously deﬁned
TASTPM mice (double hemizygotes), we have broadened the study to
investigate dose dependency of the transgene by includingmice homo-
zygous for both genes. The effect of the individual genes is also investi-
gated in mice with hemizygous expression of only one or the other
gene. When not otherwise deﬁned, TASTPM mice hence refers to the
double hemizygous mouse.ts of rising amyloidβ levels on hippocampal synaptic transmission,
iom.2018.12.006
Table 1
Antibodies used for immunohistochemistry.
Antibody Dilution Source RRID
IBA1 1:500 Wako (019-19741) AB_839504
CD68 1:500 BioRad (MCA1957) AB_322219
Aβ1-40 1:300 ThermoFisher (44-136) AB_2533599
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2.1. Animals
All experiments were performed in agreement with the UK Animals
(Scientiﬁc Procedures) Act 1986, with approval from the UCL Animal
Welfare and Ethical Review Body and in agreement with the
GlaxoSmithKline statement on use of animals. Male TASTPM mice and
C57Bl/6j mice were supplied by GlaxoSmithKline and bred either at
Charles River Laboratories International, Inc. (Margate, UK) or at UCL
by crossing male homozygous TASTPM with female C57Bl/6j. Age-
matched, non-littermate male C57Bl/6j mice were used as wild type
controls. In some experiments, double homozygous TASTPM were
bred. Single mutant TAS (APPSwe) [17] or TPM (PSEN1M146V) [15] mice
were bred by crossing hemizygous parents. Mice from Charles River
were shipped to UCL upon weaning at 21-days-old.
In this study we avoided single housing by keeping mice in large
open cages (20 cm× 35 cm× 45 cm) and enriching their environments.
Under these conditions, while the aggressive nature of the TASTPM
mouse is not completely avoided, it is less of a problem and allows
group housing to be maintained over the lifetime of the mice. Thus,
cages containing 2–8 male mice were maintained in a 12-h light/12-h
dark cycle with food (Envigo 2018 Teklad global 18% protein rodent
diet) and water ad libitum. Environmental enrichment consisted of
changes of food location, bedding type (e.g. tissue, shredded paper,
paper roll, paper bags) and inanimate objects (e.g. running wheels, ro-
dent balls, tubing, houses (mostly purchased from Eli Lilly Holdings
Limited, Basingstoke, UK)) within the cage at least once per week.
Mice were used for experimentation at the ages stated (± 0·5months)
and, where unavoidable, were single-housed for no longer than 24 h.
Tails or ear punches were used for genotyping by standard PCR proto-
cols to ensure the presence of the expected genes.
2.2. Genotyping
2.2.1. Genotype conﬁrmation using conventional PCR methods
Brieﬂy, genomic DNA was extracted using the ‘HotSHOT’ lysis
method. Alkaline lysis reagent (25 mM NaOH, 0·2 mM EDTA, pH 12)
was added to tissue samples prior to heating to 95 °C for 30 min. The
sample was then cooled to 4 °C before the addition of neutralisation
buffer (40mMTris-HCl, pH 5). The PCR reactionwasperformed through
addition ofMyTaqDNAPolymerase (Bioline) reaction buffer and primer
pairs:
TAS (APPSwe):
5’ GAATTGACAAGTTCCGAGGG 3′
5’ GGGTACTGGCTGCTGTTGTAG 3′
TPM (PSEN1M146V):
5’ GTTACCTGCACCGTTGTCCT 3′
5’ GCTCCTGCCGTTCTCTATTG 3′
using the cycling parameters: 94 °C (30 s), 58 °C (30 s), 72 °C (30 s),
for 30 cycles and a ﬁnal extension at 72 °C for 4 min. PCR product sizes
366 bp for TAS and 104 bp for TPM.
2.2.2. Immunohistochemistry
Animals were deeply anaesthetised (1:10 Euthatal:Intra-Epicaine,
National Veterinary Supplies) and transcardially perfused with 0·1 M
phosphate buffer saline (PBS) followed by 10% buffered formal saline
(Pioneer Research Chemicals Ltd). Alternatively, single hemispheres
were drop-ﬁxed immediately following brain extraction; the opposite
hemisphere used for electrophysiology. The brains were post-ﬁxed in
10% buffered formal saline for 24 h and cryoprotected in 30% sucrose/
0·03% sodium azide/PBS at 4 °C for at least 24 h before sectioning or
storage. Transverse sections were cut at 30 μm through the full left hip-
pocampus using a frozen sledge microtome (SM 2000 R, Leica) and col-
lected into a 24-well plate containing PBS/sodium azide (0·03%) for
storage at 4 °C. Serial sections were placed in separate wells until allPlease cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebwells contained a section and collection then continued serially from
Well 1 so that within each well the transverse sections were from the
length of the hippocampus at least 720 μm apart.
Standard immunohistochemical techniques were employed. For Aβ
staining only, antigen retrieval was achieved by submerging sections in
10 mM sodium citrate (pH 6·0) in 0·05% Triton X-100 and heated in a
water bath at 80 °C for 30 min. Sections for all immunohistochemistry
were then washed in PBS, followed by 0·3% Triton X-100 in PBS and
subsequent blocking in 8% horse serum/Triton/PBS for 1 h. Incubation
with primary antibody (Table 1) in blocking solution was performed
overnight at 4 °C. Sections were again washed with Triton/PBS. The ap-
propriate Alexa-conjugated secondary antibody (1:500; Invitrogen)
was added to blocking solution for a 2-h incubation at room tempera-
ture in the dark. Following PBS wash, DAPI was applied to all sections
for 5min. Sectionswerewashed for a ﬁnal time in PBS beforemounting.
Age-matched sections from wild type controls were stained in parallel
for all ages. Sectionsweremounted in anatomical order onto SuperFrost
Plus glass slides by ﬂoating on PBS and then cover-slipped using
Fluoromount G mounting medium.
2.2.3. Imaging and data analysis
Sections were imaged for quantiﬁcation using an EVOS FL Auto Cell
Imaging System (Life technologies). Tiled images were taken of the
whole transverse hippocampal section using a 20× objective. To deter-
mine cell densities, an area of 400 μm× 240 μmwas deﬁned in the CA1,
CA3 and the inner blade of the dentate gyrus. Cell counts were per-
formed using Adobe Photoshop CS6. A minimum of three sections
were used to create a mean for each animal. Sections for any given con-
dition were obtained from the same collection well within the 24-well
plate and were therefore a minimum of 720 μm apart, thus avoiding
multiple counts of the same cells. Counts of objects touching the bound-
aries of the area of interests were only included from the north and east
borders and excluded from the south and west borders.
2.2.4. Electrophysiological recordings
2.2.4.1. Acute hippocampal brain slice preparation.Micewere decapitated
and the brain rapidly removed andplaced in ice-cold dissection artiﬁcial
cerebrospinal ﬂuid (ACSF, containing (in mM): 125 NaCl, 2·4 KCl, 26
NaHCO3, 1·4 NaH2PO4, 20 D-glucose, 3 MgCl2, 0⋅5 CaCl2, pH 7·4,
~315 mOsm/l). After approximately 2 min in ice-cold dissection ACSF,
the brain was prepared for slicing by removing the cerebellum,
hemisection of the forebrain and a segment cut away from the dorsal as-
pect of each hemisphere at an angle of approximately 110° from the
midline surface to optimise slicing transverse to the hippocampus.
Each hemisphere was then glued with cyanoacrylate (Loctite 406,
Henkel Loctite Limited, UK) on this surface onto the stage of a vibrating
microtome (Integraslice model 7550 MM, Campden Instruments,
Loughborough, UK) containing frozen dissection ACSF and 400 μm
transverse slices of hippocampus cut. As each slice of a hemisphere
was cut, the hippocampus was dissected out, retaining a portion of en-
torhinal cortex and the resulting smaller slicewas placed into a chamber
containing ‘Carbogenated’ (95% O2/5% CO2; BOC Limited) dissection
ACSF at room temperature (approximately 21 °C). After 5 min, slices
were then transferred into a fresh chamber held at 36 °C with the
same dissection ACSF. At 5 min intervals, they were then consecutively
transferred to physiological Ca2+ and Mg2+ ion concentrations (in
mM): i) 1 Mg2+, 0⋅5 Ca2+; ii) 1 Mg2+, 1 Ca2+; iii) 1Mg2+, 2 Ca2+.ts of rising amyloidβ levels on hippocampal synaptic transmission,
iom.2018.12.006
4 E. Medawar et al. / EBioMedicine xxx (2018) xxx2.2.4.2. Patch-clamp recordings in brain slices. Once transferred to 1 Mg2
+, 2 Ca2+ ACSF, slices were allowed to return to room temperature
and after at least a further 40min recovery time, a single slicewas trans-
ferred to a submerged chamber and superfused with recording ACSF
(containing (in mM): 125 NaCl, 2·4 KCl, 26 NaHCO3, 1·4 NaH2PO4, 20
D-glucose, 1MgCl2, 2 CaCl2, bubbledwith Carbogen). Individual CA1 py-
ramidal or dentate gyrus granule neurones were visualised using
infrared-differential interference contrastmicroscopy on an uprightmi-
croscope (model BX50WI, Olympus, UK). Glass microelectrodes for
patch-clamp were pulled from borosilicate glass capillaries (Catalogue
number GC150F-7.5, 1·5mmOD× 0·86mm ID, Biochrom-Harvard Ap-
paratus Ltd., Cambridge, UK) on a vertical puller (model PP830,
Narishige International Ltd., London UK). Electrodes (tip resistance
approximately 5 MΩ) were ﬁlled with a CsCl-based internal solution
(containing (in mM): 140 CsCl, 5 HEPES, 10 EGTA, 2 Mg-ATP, pH 7·4,
~290 mOsm/l). Patch-clamp recordings were performed using an
Axopatch 1D (Molecular Devices, Sunyvale, CA, USA), and current sig-
nals low-pass ﬁltered at 10 kHz then 2 kHz (Brownlee Precision
Model 440, NeuroPhase, Santa Clara, CA, USA) during digitization
(10 kHz; 1401plus, Cambridge Electronic Design, Limited, Cambridge,
UK) and acquired using WinWCP (for isolated events; version 4.6.1;
John Dempster, Strathclyde University, UK) and WinEDR (for continu-
ous recordings; JohnDempster, StrathclydeUniversity, UK). Stimulation
was applied via a patch electrode ﬁlledwith ACSF, placed extracellularly
in the appropriate axon path using a square pulse constant-voltage
stimulator (100 μs; DS2A-MkII, Digitimer Ltd., UK) triggered by
WinWCP.
WinEDR synaptic analysis software was used for detection of spon-
taneous andminiature currents andWinWCP used to analyse identiﬁed
spontaneous, miniature and evoked currents. Criteria for detection of
spontaneous or miniature currents was to remain over a threshold of
3 pA for 2 ms. Currents were inspected by eye and only included if the
rise time was b 3 ms and faster than the decay.
2.2.4.3. Field potential recordings in brain slices. Slices were transferred as
needed to a heated (30 ± 1 °C) submerged chamber and superfused
with ACSF and allowed to recover for 1 h in the recording chamber. A
glass stimulating electrode (ﬁlled with ACSF, resistance ~2 MΩ) and
an identical recording electrode (connected to an AxoClamp 1B via a
1× gain headstage) were both positioned in stratum radiatum of the
CA1 ﬁeld to obtain a dendritic excitatory postsynaptic ﬁeld potential
(fEPSP). Recordings were controlled and recorded using WinWCP soft-
ware (as above), ﬁltered at 10 kHz and subsequently at 3 kHz and digi-
tized at 10 kHz via amicro1401 interface (Cambridge Electrical Designs,
UK). Stimuli (constant voltage 10-70 V, 100 μs; model Digitimer DS2A-
MkII or Grass SD9) were applied at 0·1 Hz and resultant fEPSPs subse-
quently averaged over consecutive 1-min intervals. Stimulation inten-
sity was set at approximately 30–50% of the intensity required to
evoke a population spike or the maximum fEPSP amplitude obtained
and a ≥ 15-min stable baseline recorded. LTP conditioning was applied
at test-pulse stimulus intensity and consisted of either 3 trains of tetani,
each consisting of 20 pulses at 100 Hz, 1·5 s inter-train interval; or 4
trains of theta-burst stimuli, each train consisting of 4 pulses at
100 Hz repeated 8 times at 20 Hz; inter-train interval 1 min. Following
conditioning, fEPSPs were evoked at 0·1 Hz for 1 h.
2.2.5. Behavioural testing
2.2.5.1. T-maze forced alternation task. Previously reported methods,
optimised for mouse, were used to assess hippocampus-dependent
learning [18]. Mice were food deprived to 90% free-feeding-weight, be-
ginning 2 days before the start of the habituation phase and with ad
libitum access to water. Each mouse was handled at the start of food
deprivation and throughout T-maze habituation for 15–20 min per
weekday.Please cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebThe T-maze was constructed from three arms, each measuring 50
cm × 8 cm with 10 cm colourless Perspex walls and a grey ﬂoor,
mounted on a table in the centre of a roomwith numerous distal visual
cues, such as black and white posters on the walls. Black barriers were
used to block the start and goal arms. Reward consisted of a drop of Nes-
tlé Carnation™ condensed milk that was placed at the end of each goal
arm. Arms were cleaned with 70% ethanol between all runs to reduce
odour cues. In addition, in an inaccessible well a drop of reward is al-
ways present in both arms.
Mice received 4 days of habituation to the maze, during which time
they were allowed to explore the maze for 5 min with all arms open.
During the ﬁrst two days of habituation, reward was scattered along
the ﬂoor and in foodwells to encourage exploratory behaviour; then re-
stricted to only the foodwells at the ends of the goal arms in the last two
days.
The behavioural regime lasted for three weeks, with ﬁve days of
training per week. Each day, animals received six trials; each trial
consisted of a sample and choice run. In the sample run, one arm was
blocked off. The mouse was placed at the starting point at the base of
the T, the barrier was removed and the mouse was allowed to go to
the available arm and given 20 s to eat a drop of reward from the food
well. For the choice run, the mouse was immediately returned to the
starting point and the barrier in the previously blocked arm removed.
The starting barrier was then raised and the animal allowed to choose
between the two arms but only rewarded if it chose the previously un-
visited arm. Thus, a correct choice was scored when themouse selected
the arm not visited in the sample run. After the choice run, the mouse
was removed from themaze and placed in its holding box. The location
of the sample arm (left or right) was varied pseudorandomly across the
session and mice received three left and three right presentations, with
nomore than two consecutive trials with the same sample location. An-
imals were allowed a maximum of 5 min to make a choice to enter a
goal arm in both runs before a trial was aborted. If an incorrect arm
was chosen during the choice run, the mouse was conﬁned in the arm
with no reward for 20 s and then removed from the maze.
During the ﬁrst two weeks of training the choice run followed im-
mediately after the sample (test) run (there was a delay of approxi-
mately 15 s between runs for cleaning and resetting the maze). Data
was analysed in blocks of 2 days and hence blocks 1–5 represent the
ﬁrst 2 weeks of training.
On the ﬁrst day of the third week, mice received a repeat of the pre-
vious training sessions in order to assess retention of the task (block 6).
On the following four days, longer delays (2–10 min) were introduced
between the sample and choice runs to extend the time that the previ-
ous choicewas to be held inmemory (blocks 7 and 8 in response times).
During these intervals, each animal was placed in a separate holding
box. Each mouse received two of each of the delay periods per day, var-
ied pseudorandomly bothwithin and across days. Response times were
calculated from the time that the starting block was removed until the
mouse made a choice of arms and all four paws had crossed the entry
point. Squads of 15–17 mice were run per day. During training, data
are presented as blocks averaged across 2 days for each animal and
expressed as mean ± SEM. For delays the four runs for each delay are
averaged.2.2.5.2. Elevated plus maze. The plus-maze was constructed from two
enclosed arms (30 cm × 5 cm × 20 cm) and two open arms (30 cm
× 5 cm × 0⋅8 cm) connected by a small central platform (5 × 6 cm);
the two closed and two open arms were positioned opposite each
other, respectively. The maze was elevated 30 cm above a table.
Mice were placed in the centre of the plus maze facing an open arm
and allowed to freely explore the maze for one 6-min trial. The time
spent on each arm (open versus closed) was recorded, as well as the
number of entries into the arms. An entry into an arm was deﬁned as
all four paws resting on a given arm.ts of rising amyloidβ levels on hippocampal synaptic transmission,
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5E. Medawar et al. / EBioMedicine xxx (2018) xxx2.2.5.3. Open ﬁeld. The open ﬁeld consisted of a plastic cylinder (diame-
ter: 47·5 cm, height 36 cm)with awhite plastic ﬂoor. Micewere placed
on the periphery of the open ﬁeld ﬂoor and allowed to explore freely for
30min. The path of eachmouse was recorded using dacQUSB recording
system (Axona, St. Albans, U.K) at a sample rate of 50 Hz. The open ﬁeld
was optically divided into a central circle and a peripheral ring, each
with equal area. The path of the mouse was analysed ofﬂine using
ImageProPlus. Path length and dwell times in the periphery and centre
were calculated using custom made routines written in Matlab R2010a
(MathWorks).
2.2.5.4. Light/dark box. The dark box [19] measured 20 cm × 20 cm
× 30 cm, with black walls, ﬂoor and lid. The light box measured 30 cm
× 30 cm × 30 cm with a white ﬂoor and light grey walls. The boxes
were connected by an opening in the partition between the two com-
partments. An overhead light provided bright illumination in the light
box. Mice were placed in the centre of the light compartment facing
away from the opening and then allowed to explore for a period of
6 min. Time spent in each box and the number of entries into each
box were recorded. An entry into a box was deﬁned as all four paws
resting inside the given box.
2.3. Statistics
All data analysis was carried out blind to genotype. All statisticswere
performed using Graphpad Prism 6 with appropriately designed two-
tailed t-test or ANOVA. Post hoc tests were only performed if a signiﬁ-
cant interaction between the independent variables was obtained. Ani-
mals were considered as independent samples and, where multiple
data were collected from an animal, these were averaged (mean)
prior to pooling. Thus sample sizes represent the number of animals.
Unless stated otherwise, data are presented as mean± SEM and differ-
ences considered signiﬁcant at p b 0·05.
3. Results
3.1. Plaque development in hippocampus
In TASTPM mice of different ages, individual plaques were counted
in the hippocampus and their sizesmeasured to assesswhether the dis-
tribution changed over time (Fig. 1). Initially, at 3–4months of age, only
small plaques could be detected (b 100 μm2) and thesewere very sparse
(Fig. 1a-c). However, the number of small plaques increased exponen-
tially, initially approximately doubling every month, and continuing to
increase at a slower rate until 14 months of age (Fig. 1b). Hence, at
least up until this age, new plaques were being seeded. By 7 months
plaques up to 200 μm2 were consistently seen but were similar in fre-
quency to the smallest plaques at 3–4months, presumably representing
the growth of the earliest seeds. Plaques of N 500 μm2were only consis-
tently detected at ages over 10 months but, from this age on, a wide
range of plaques sizes were evident, with occasional plaques of over
2500 μm2 detected. Interestingly, between 14 and 15 months of age,
very little change in the number of plaques was detected but the largest
plaques continued to grow. As individual plaques were not tracked over
time, we cannot be entirely sure that the progression up to 14months is
due to continuous seeding of small plaques that gradually grow with
ongoing plaque deposition; however, this seems the most likely expla-
nation. The fact that the rate of addition of small plaques decreases grad-
ually until it plateaus around 14 months of age suggests that, as the
plaques get denser, some of the small plaques start to fuse with larger
plaques. In some cases, large plaques were present that possessed a
halo of Aβ around the dense core,with dense puncta of Aβ visiblewithin
the halo, possibly representing more recently seeded plaques being
engulfed as the large plaque grows (Fig. 1a).
When the gene-dose was doubled by using double homozygous
TASTPM mice, plaques were ﬁrst detected at about 2 months of age
(Fig. 1e). Similarly to the hemizygous mice, plaque density and sizePlease cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebincreased with age but perhaps surprisingly, did not reach a greater
density than that observed in the hemizygotes.
Mice carrying only the single mutations were also examined. In TAS
mice (APPSwe), small plaqueswere detected at 16months.While plaque
density and size increasedwith age, plaque loads did not reach that seen
in the double mutant TASTPM mice, even at the very advanced age of
27months. In TPMmice (PSEN1M146V), there were no plaques observed
at any age.ts of rising amyloidβ levels on hippocampal synaptic transmission,
iom.2018.12.006
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Having previously observed that a module of microglial genes in-
creased in expression in Αβmice (including TASTPM) in close correla-
tion with plaque load [10], we went on to examine the densities of
total and CD68 positive of microglia in more detail in these mice
(Fig. 2). There was an increased density of microglia (assessed by Iba1
positive cells) in CA1 at very early ages, with increases (approximately
double) compared to wild type already evident by 2 months of age,
even before plaques could be detected (Fig. 2a&c; 2–8 months, n =
6–12, two-way ANOVA, p b 0·01). However, note that Aβ levels are al-
ready raised by 2 months [16] and it is possible that small plaque seeds
(b the 10 μm2 threshold) may already be depositing at this time. There
was also an age-dependent increase in Iba1 positive microglia in both
wild type and TASTPM mice at around 10 months of age.
In contrast to total microglia, the microglial phagocytic phenotype,
as measured by CD68 labelling, was very low in all young animals and
only increased from around 10–12 months. Again, this happened in
bothwild type and TASTPMmice. The percentage of phagocyticmicrog-
lia tended to be slightly higher in TASTPM mice as compared to wild
type (14–20 months, n= 5–9, two-way ANOVA p= 0·07). This coin-
cided with the appearance of large plaques (Fig. 1c&d). Interestingly,
the number of microglia and their CD68 status seem to plateau at this
stage, with no further increase in density beyond 12 months of age.
When the double homozygous TASTPMmicewere examined, a very
similar pattern was observed for densities of both total microglia and
CD68 positive microglia (Fig. 2d). As expected both plaque load and
microglial response was greater in the homozygous mice.
Sections from single mutant mice were also stained for both IBA1
and CD68. The APPSwe TAS mice, which develop plaques from around
16 months (Fig. 1f), had a higher total and CD68 positive microglia at
both 18 and 27 months of age (main effects of genotype for both Iba1
and CD68 in separate two-way ANOVAs; p b0⋅05). In contrast, the
PSEN1M146V TPM mice, which do not develop plaques at any age,
showed nodifference fromwild typemice in theirmicroglial phenotype
at 4 months of age for either total or CD68 positive microglia (Fig. 2g,
two-tailed t-test, p N0⋅5).
Very similar changes in total microglial and CD68 positivemicroglial
densities were found in dentate gyrus, CA3 and subiculum (data not
shown).
3.3. Synaptic currents in CA1 neurones
3.3.1. Spontaneous excitatory activity
When spontaneous excitatory currents are recorded from CA1 pyra-
midal neurones in the presence of a GABAA receptor antagonist
(gabazine, 6 μM), the substantial loss of spontaneous activity we have
previously reported up to 4 months of age [16] is largely maintained
through to 18 months (Fig. 3a). At 8 months there was almost a com-
plete loss of action potential-dependent spontaneous activity in the
transgenic mice (Fig. 3aii), with the frequency almost exactly the
same as that of miniature currents (Fig. 3aiii) observed in the presence
of 1 μM tetrodotoxin. This result was almost identical to what we haveFig. 1. Plaque development in TASTPM mice. a) Representative micrographs of Aβ40
(green) immunoﬂuorescence in hippocampus from 3- to 15-month-old hemizygous
TASTPM mice. Scale bar 250 μm. b) Plaque density measured at different ages in
TASTPM mice (n = 2–3 animals per age group). c) Proportion of plaques of indicated
sizes contributing to increased percentage coverage of the hippocampus with increased
age. d) Density of plaques within speciﬁc size ranges (as indicated on x-axis) over age
(colours as indicated in key). The inset covers smaller bin sizes for plaques up to 200
μm2. Note the split y-axis. e) Density of homozygous TASTPM plaques within speciﬁc
size ranges (as indicated on x-axis) over age (colours as indicated in key). Note the split
y-axis f) Density of TAS plaques within speciﬁc size ranges (as indicated on x-axis) over
age (colours as indicated in key). Note the different x and y-axes in f compared to d and
e, with few plaques and maximum plaque area under 500 μm2. All data are represented
by mean ± SEM. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
Please cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebpreviously reported at 4 months. By 12–18months, a decrement in fre-
quency of miniature EPSCs had also developed but the action potential
mediated spontaneous excitatory current frequency, although signiﬁ-
cantly lower in transgenic mice than wild type mice, were at a higher
frequency than the miniature currents in the same genotype, implyingts of rising amyloidβ levels on hippocampal synaptic transmission,
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ring in the transgenic mice at these older ages (Fig. 3a). There were no
differences between genotypes ofmEPSC amplitudes or decay time con-
stants (data not shown).
When excitatory activitywas evoked by stimulating the Schaffer col-
laterals in slices from older animals, the previously reported increase in
release probability at 4 months, as assessed by a lower paired-pulse fa-
cilitation and conﬁrmed by a reduction in failure to release glutamate in
response to minimal stimulation [16], was maintained. Thus, at
12 months of age, paired-pulse ratio was lower in TASTPM than wild
type mice at both 25 and 50 ms inter-stimulus intervals (n = 5–8,
two-way ANOVA, main effect of genotype p b 0⋅02), while
at 18 months of age, the lower paired-pulse ratio was only evident
at 25 ms, resulting in a genotype × interval interaction (p b 0⋅05) and
a highly signiﬁcant Sidak post hoc pairwise comparison between geno-
type at 25 ms (p b 0⋅005).
3.3.2. Inhibitory activity is unchanged
Althoughwehave concentrated our detailed analysis on glutamater-
gic activity, we were able to gain an overview of inhibitory activity from
the spontaneous activity recorded in the absence of antagonists by
utilising CsCl as the internal patch pipette solution. Hence, in the exper-
iments examining pharmacologically isolated EPSCs above, initially
spontaneous currents were recorded in the absence of receptor antago-
nists. When the GABAA receptor antagonist was included in the perfu-
sion solution, the frequency of currents was decreased to about 5–10%
in wild type slices. Consequently, GABAA receptor-mediated activity
contributes about 90% of the frequency of the initial recording of
mixed spontaneous activity. Note that, if the recording were made in
the presence of a glutamatergic antagonist, any currents that were due
to spontaneous glutamatergic activity mediating feed-forward or feed-
back inhibition would be lost. Hence, the assessment of the drug-free
frequency is a better assessment of the contribution of inhibition with
the understanding that this will overestimate frequency by about 10%.
Under these conditionswe ﬁnd that there is no signiﬁcant change in in-
hibitory synaptic activity in TASTPM mice at any age from 4 to
18 months (Fig. 3c). Note that, considering the very substantial change
in spontaneous glutamatergic activity, this implies that very little of the
GABAergic activity is dependent on glutamatergic input.
3.3.3. Synaptic plasticity is altered in TASTPM mice
Considering the changes in excitatory transmission it seemed likely
that synaptic plasticity, in particular long-term potentiation (LTP), the
best cellular model we have for the laying down and retrieval of mem-
ory [20], could be altered. To assess effects on LTP, ﬁeld potentials were
recorded from CA3-CA1 synapses in acute brain slices prepared from
TASTPM mice at ages preceding detectable Αβ plaques (2 months)
through to ages with a heavy plaque load (12–18 months).
Field input-output relationship was not signiﬁcantly changed at any
of the ages tested (Fig. 4a).Moreover, unlike our previously reported re-
sult using patch clamp recording in the presence of a GABAA receptor
antagonist [16], in ﬁeld recordings with the inhibitory network intact,
paired-pulse ratios were not signiﬁcantly changed between genotypesFig. 2.Microglial proliferation and activation in TASTPMmice. a) Microglia (Iba1, green)
cluster around plaques (Aβ1–40, red) in TASTPM mouse hippocampus (nuclei: DAPI,
blue). Scale bar 250 μm. b) Examples of phagocytic microglia (CD68, red + Iba1, green;
yellow when colocalised) in wild type and TASTPM hippocampus. Scale bar 25 μm.
c) Total microglial density (Iba1+, full bar height) and phagocytic microglial (Iba1
+ CD68+, black bar) density in hemizygous TASTPM mice with age. Sigmoidal ﬁts are
shown (Iba1 green; CD68 red): unbroken lines, TASTPM; dashed lines, wild type (only
ﬁt shown for wild type). d) Total and phagocytic microglial densities in homozygous
TASTPM mice with age. Sigmoidal ﬁts are shown. e) Total and phagocytic microglial
densities in the APPSwe TAS mice at the ages shown. Signiﬁcant main effects of genotype
for both IBA1 and CD68 are indicated by *p b 0⋅05. f) Densities of total microglia and
CD68 positive phagocytic microglia in 4 month old PSEN1M146V TPM microglia. All data
are represented by mean ± SEM. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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changes in paired-pulse ratio were masked when GABAergic activity
was not blocked, presumably, at least in part, by feed-forward inhibition
decreasing release on the second stimulus.
At 2 months of age, LTP is altered in TASTPMmice but this is depen-
dent on the induction protocol. When LTP was induced by tetanic stim-
ulation in these young mice, the magnitude of LTP was greater in slices
from TASTPM than from wild type mice. Paired-pulse ratios remained
unaltered when the last ten minutes of the post-induction recordings
was compared to the baseline in both genotypes (Fig. 4c&d). This sug-
gested that the change in amplitude seen in LTPwas due to a postsynap-
tic change. In contrast, when LTP was induced using theta-burst
stimulation, there was no difference between the wild type and
transgenic mice (Fig. 4e). Surprisingly, however, despite LTP remaining
unchanged after theta-burst stimulation, the paired-pulse ratio de-
creased signiﬁcantly between the pre-induction baseline and the last
10min of LTP in the TASTPMbut not in thewild typemice. This suggests
that the locus of expression of this form of LTP is likely to have a presyn-
aptic component in transgenic mice at this age. Note that, considering
an increase in release probability would be expected to enhance the
postsynaptic response, this would suggest that the postsynaptic contri-
bution to LTP could be decreased in the transgenic mice possibly with
one locus of change compensating for the other.
At 4months of age, the effects of the different stimulus protocols had
changed. By this age, a clear deﬁcit was seen in LTP induced by tetanic
stimulation, which was the reverse change to that seen at 2 months.
Moreover, similar effects were seen in two separate cohorts of
4-month-old mice (cohort 1 shown in Fig. 4c; pooled data shown in
Fig. 4d).
TBS-induced LTP (Fig. 4e)was, like at 2months, of similarmagnitude
between genotypes but analysis of paired-pulse ratios, following LTP in-
duction, indicated that LTP has a similar locus of expression in the two
genotypes.
In addition, chemically-induced LTPwas also examined in a separate
set of slices, using transient application of thepotassiumchannel blocker
tetraethylammonium, applied after completion of a tetanus-induced
LTP experiment. As expected, tetraethylammoniumapplication resulted
in an initial reduction in theﬁeld potential, followedbya long-lasting in-
crease after wash-out. The magnitude of the tetraethylammonium-
induced LTP was unchanged in slices of TASTPM compared to wild
type animals (data not shown). This conﬁrms that, despite deﬁcits in
tetanus-induced LTP, TASTPM are capable of expressing LTP under
other induction protocols.
The deﬁcit in tetanus-induced LTP was maintained at 12 and
18 months of age (Fig. 4e).
3.3.4. Synaptic plasticity in TAS and TPM mice
The induction of LTP was also examined in 24 month old single mu-
tant mice (Fig. 4f-h). In age-matched wild type mice, LTP magnitude
was similar to that observed at younger ages. In the APPSwe TAS mice,
the magnitude of LTP was smaller than wild type mice (Fig. 4f). In con-
trast, in the PSEN1M146V TPM mice, the magnitude of LTP was greater
(Fig. 4g). There was an overall signiﬁcance between genotypes by
one-way ANOVA (p b0⋅05; Fig. 4h, Fisher LSD post hoc tests versus
wild type p=0⋅1 for TAS and p=0⋅05 for TPM).
3.4. Cognition and behaviour
3.4.1. TASTPM mice show rigidity in hippocampus-dependent learning
The hippocampus-dependent forced-alternation T-maze task was
used to assess cognition in the TASTPM mice at three ages (Fig. 5):
4 months, which corresponds to the ﬁrst appearance of Αβ plaques
(Fig. 1) and where tetanus induced LTP was ﬁrst impaired (Fig. 4);
8 months, a moderate plaque load and 12 months, a heavy plaque
load. Due to availability of animals, in this set of experiments, the 4-
month-old group was run as three cohorts (no signiﬁcant differencets of rising amyloidβ levels on hippocampal synaptic transmission,
iom.2018.12.006
Fig. 3. Excitatory and inhibitory synaptic transmission in TASTPM mice. ai) Example spontaneous and miniature EPSCs recorded from 18-month-old TASTPM. aii) Frequency of
spontaneous EPSCs. Main effect of genotype by two-way ANOVA (§§ p = 0⋅0011). aiii) Frequency of miniature EPSCs. Main effect of genotype by two-way ANOVA (§§ p b 0⋅01) bi)
Example responses evoked by paired stimuli. bii) Paired-pulse ratios from 12-month-old mice. Main-effect of genotype by two-way ANOVA (p= 0⋅02). biii) Paired-pulse ratios from
18-month-old mice. Genotype × inter-stimulus interval interaction (p b 0⋅05); Sidak post-hoc test is indicated (p= 0⋅002). ci) Example continuous recordings of spontaneous IPSCs.
cii) Spontaneous IPSC frequencies. Sample sizes are indicated by the numbers within bars or within parentheses. * p b 0⋅05; ** p b 0⋅01. All data are represented by mean ± SEM.
8 E. Medawar et al. / EBioMedicine xxx (2018) xxxbetween the cohorts); while the 8- and 12-month-old groupwere a sin-
gle cohort that underwent repeat training in a longitudinal study. It
should be noted that at both 4 and 8 months of age, a subset of
TASTPM mice did not complete the task in the required time and
these mice were not included in the ﬁnal results (1 of 16 mice at
4 months of age and 3 of 13 mice at 8 months of age).
At 4 months of age, both genotypes started training at similar levels
of performance and improved over the trainingperiod (Fig. 5a, two-way
ANOVA, main effect of 5 block training period, p = 0⋅01). However,
TASTPM performed signiﬁcantly worse than wild type mice overall
(main effect of genotype, p b 0⋅003), and there was no signiﬁcant inter-
action between training block and genotype. Interestingly in Block 6,
after 2 dayswithout training, the two groups came togetherwith almostPlease cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebidentical performance at 90% correct choices (Fig. 5a). When extra de-
lays (2–6 min) were then added between the sample and choice runs
a slight decrement in performance occurred, as expected, but there
was no difference between genotypes (Fig. 5b). In terms of the behav-
iour within the trials it was notable that on both the sample and choice
runs the TASTPM mice showed considerably longer response times. In
the case of the choice run, thismay have inﬂuenced the result, especially
the apparent impairment during the training period, as the time that
memory needed to be retained was more than doubled (Fig. 5c).
At 8 months of age, TASTPM performed similarly to wild type mice,
improving over the training period (two-way ANOVA, main effect
of training period (p b 0⋅0001). When the same mice that were run
at 8 months were retested at 12 months of age, wild types had, asts of rising amyloidβ levels on hippocampal synaptic transmission,
iom.2018.12.006
Fig. 4. Field EPSP recordings of synaptic plasticity in TASTPMmice. a-c) 2 months upper row; 4 months lower row. a) Input-output relationship, b) Paired-pulse ratio proﬁle and c) Time
course of tetanus-induced LTP: fEPSP (upper panels) and paired-pulse ratio (PPR, lower panels) after induction as a percentage of pre-induction baseline. Traces are representative fEPSPs
from baseline (grey) and the 51–60 min after tetanus (black). Scale bars: 5 ms × 0⋅5 mV. d) Magnitude of LTP (left) induced by tetanus over 2–18 months of age (number of mice as
indicated in each column). Two-way ANOVA revealed signiﬁcant age × genotype interaction (p b 0.0001). Change in paired-pulse ratio (right) following LTP induction. Both wild type
and TASTPMmice showed a signiﬁcant decrease in PPR compared to baseline at both ages (paired t-tests within separate experiments; p b 0⋅05). No signiﬁcant difference between ge-
notypes (two-way ANOVA). e) Magnitude of LTP induced by theta-burst stimulation (left, no signiﬁcant difference between genotypes) and corresponding change in paired-pulse ratio
(right; two-way ANOVA age × genotype interaction p b 0⋅05). Sidak post hoc test: *p b 0⋅05; ****p b 0⋅0001. f) LTP induced by tetanic stimulation in APPSwe TAS mice at 24 months of
age. g) LTP induced by tetanic stimulation in PSEN1M146V TPM mice at 24 months. Wild type animals are common to both panels f and g. h) Magnitude of LTP induced in 24 month old
wild type, TAS and TPMmice. 24 month old recordings for all genotypes were interleaved; signiﬁcance tested by one-way ANOVA, *p b 0⋅05. All data are represented by mean ± SEM.
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rect and again improved from ~75% to ~90% during the training period.
Unexpectedly however, TASTPM appeared to have retained their previ-
ous training, starting the training at ~90% and showed no further im-
provement over the training period. This was reﬂected in a signiﬁcant
interaction between training period and genotype in a two-way
ANOVA (p b 0⋅03, Fig. 5a).Please cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebAnimalswere again challenged further by the introduction of a delay
between sample and choice runs (Fig. 5c). While at 8 months there was
no difference between genotypes, at 12 months of age although
TASTPM mice showed a similar decrement with the longest delays
their performance with a 2·5 min delay between sample and choice
runs was surprisingly better than their wild type counterparts (two-
tailed t-test, p b 0⋅05).ts of rising amyloidβ levels on hippocampal synaptic transmission,
iom.2018.12.006
Fig. 5.Hippocampus-dependent T-Maze learning in TASTPMmice. a-c) Ages as indicated above panel a. a) Probability of mice making a correct choice in the choice run at 4 months (n=
15–16 animals completing the task), 8 months (n= 10–13 animals completing the task) and 12 months of age (wild type n= 15; TASTPM n= 8). At 4 months of age there was a main
effect of genotype in a two-way ANOVA (§§ p b 0⋅01). Note the difference in starting performance at 12months of age. These are the samemice tested at 8months. As expectedwild type
mice started at around 75% correct choices and improved with training having, extinguished their previous training. TASTPM mice unexpectedly started training making correct
choices 90% of the time having retained the previous improved level. Two-way ANOVA interaction between training block and genotype (p b 0⋅03); Sidak post hoc analyses are
indicated by *p b ⋅05, **p b 0⋅01. b) The introduction of delays between sample and choice runs revealed no further differences between genotypes at 4 or 8 months of age, while at
12 months, a signiﬁcant effect of genotype was observed with TASTPM mice retaining performance despite a 2⋅5 min delay before the choice run († p b 0⋅05). c) Response time for
choice run at 4–12 months of age, Sidak post hoc analyses are indicated by *p b 0⋅05, **p b 0⋅01, ***p b 0⋅001, ****p b 0⋅0001. All data are represented by mean ± SEM.
10 E. Medawar et al. / EBioMedicine xxx (2018) xxxAnother interesting difference between the 12-month mice and the
younger groups was that the response time for the choice run for
TASTPM mice at 12 months was rapid and no different from the wild
type mice (Fig. 5c). (Note, at this age the mice also always completed
the task in the required time.) In contrast, as described for 4 months
above, the 8-month-old TASTPM mice showed a considerable delay to
respond. However, despite this delay again increasing the time that
memory needed to be retained, the 8 months mice showed no decre-
ment in correct choices.
These failures and delays to respond may be interesting in terms of
early behavioural changes and may also suggest different levels of
anxiety.
3.4.2. TASTPM mice show decreased activity and increased anxiety-related
behaviour compared to wild type mice
In the light of the behavioural differences seen in the T-maze trials,
locomotor activity and anxiety were assessed using a battery of tests.Please cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebFirst, mice were placed in an open ﬁeld (Fig. 6a). TASTPM mice had
shorter total path lengths than their wild type counterparts at all ages
(Fig. 6ai; two-way ANOVA, main effect of genotype, p b 0⋅0001; no
interaction between age and genotype). Furthermore, TASTPM mice
spent more time in the peripheral than central area (Fig. 6aii;
two-way ANOVA, main effect of genotype, p b 0⋅0005; main effect of
age, p b 0⋅0001).
Secondly, at 8 months of age, TASTPMmice spend more time in the
closed than open arms of an elevated plus maze (two-way ANOVA
interaction between age and genotype p b 0⋅05); at 4 and 12 months
of age this difference was not evident (Fig. 6b).
Finally, at 4 and 8 months of age, TASTPM mice spent more time in
the closed compartment of a light/dark box (12 months not tested).
There was a signiﬁcant interaction between age and genotype (Fig. 6c;
p b 0⋅05).
Overall, these data indicate an increased level of anxiety in TASTPM
mice from early stages of plaque development especially at earlier ages.ts of rising amyloidβ levels on hippocampal synaptic transmission,
iom.2018.12.006
Fig. 6. Open ﬁeld and tests of anxiety. a) Open ﬁeld test. ai) Total path length run over 30mins. Main effect of genotype by two-way ANOVA (§§§ p b0⋅001). aii) Time spent in peripheral
area. Main effect of genotype by two-way ANOVA (§§§§ p b 0⋅0001). b) Elevated plus maze. Relative time in closed arm. c) Light/dark box. Relative time spent in dark compartment
(12 months not testEd.) In b and c, Sidak post hoc tests are indicated (two-way ANOVA genotype × age interaction p b 0⋅05; * p b 0.05; ***p b 0⋅001; **** p b 0⋅0001). All data are
represented by mean ± SEM.
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Proliferation ofmicroglia, particularly clustering aroundplaques, has
been repeatedly reported in Alzheimer's disease, both in the human
condition and in mouse models [21–23]. Moreover we have previously
reported a close correlation between plaque load and a microglial
coexpression module in TASTPM mice. This reveals not only changes
in expression of the gene for the phagocytic protein CD68, tested with
immunohistochemistry in the present study but also even greater
changes in Trem2 expression [10], a gene shown in humans to be impor-
tant in Alzheimer's disease in GWAS [24,25]. However, here we show
increased density of microglia, even before plaques can be detected in
this mouse model. This ﬁnding required immunohistochemistry and
cell counts as the gene expression changes of such speciﬁc microglial
genes would only be apparent in whole tissue analysis with very large
changes, such as occurs in later stages. In the light of previous reports
[21–23], proliferation seems the most likely explanation of the in-
creased density, although other causes such as increased survival of mi-
croglia or migration into the hippocampus, are possible. The triggering
of microglial proliferation may be due to soluble Αβ in the wider
neuropil, as seem to be the case for the earliest synaptic changes [16].
In addition, it is possible that initial seeds of plaques are already present
at this early stage but are too small to detect, being below the detection
threshold set here (b10 μm2), which are either detected directly by
microglia, or via secondary messengers, particularly altered pro- or
anti-inﬂammatory cytokine levels within the environment (reviewed
in reference 26).
In either case, the question arises as to how plaque development
then continues and how this relates to increased microglial numbers
and development of a reactive phagocytic phenotype. Once plaques
are seeded at these early stages, the ongoing deposition may primarily
contribute either to the growth of plaques or to the seeding of new
plaques. It is also possible that large plaques are not the result of smaller
plaques growing but rather due to the fusion of smaller plaques. Here
we observe that the smallest plaques initially increase in number, al-
most doubling eachmonth. This deposition continues to increase, albeit
not quite so rapidly, at least until about 14 months of age when the
number of plaques plateaus. This suggests that small plaques are seeded
throughout the ages tested and gradually grow to form the larger
plaques. Presumably the rapid increase in the seeding of plaques during
the early stages relates to the rapid increase in Aβ levels at this stage
that we have previously reported [16]. The plateauing of density of
smaller plaques may also reﬂect them gradually being engulfed as the
larger plaques spread and thus they are no longer seen as separate enti-
ties. This is strongly suggested by the appearance of brighter spots of AβPlease cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebin the halo around some of the larger plaques as can be seen in Fig. 1a
from 10 months onwards.
As plaques form,wehave previously showna very strong correlation
with microglial gene expression [10]. This encompasses both prolifera-
tion and activation of microglia. While there are more microglia very
early in these Αβ mice, their phagocytic phenotype appears later and
seemsonly to be triggered once the larger plaques of N 500 μm2develop.
However, it is important to note that a step up in the density of total and
CD68 positivemicroglia also occur at this stage in thewild typemice. Al-
though the number of microglia and their activation state remains
higher in the TASTPM mice the similarity in the timing of this later
stage in both genotypes suggests that this has a strong age-related com-
ponent rather than being purely dependent on the presence of plaques.
However, it is also interesting to note that in the homozygous TASTPM,
which develop plaques earlier but plaque load plateaus at the same
level as the hemizygous mice, the density of total microglia and CD68
positive microglia is higher than in hemizygotes. Furthermore, the
absence of a microglial phenotype in the TPM mice, while the TAS
mice show a similar phenotype excludes a direct effect of the mutant
presenilin on microglial function.
As has been previously shown in TASTPM [10] and other transgenic
mice (for example, see reference 22), the microglia are strongly
attracted to and cluster tightly around the plaques as they grow. The
question arises as to what the microglia are actually doing in the Αβ
mice. The assumption previously has been that they are removing or
limiting expansion of plaques [22]. Conversely, it has been repeatedly
reported that removal of microglia by blocking CSF1R has no effect on
plaque load [27–29], although a role formicroglia in initial plaque depo-
sition has been suggested [30], which may be related to the initial early
rise in microglia numbers, even preceding detection of plaques. It is,
however, clear in the TASTPM mice that, since plaques continue to
grow in both size and number in parallel to rapid microglial prolifera-
tion, it does not seem that microglia are very effective at removing Aβ.
Recently interesting evidence has been presented that Aβ stimulates
microglia to phagocytose synapses in a complement dependentmanner
at early stages of plaque development in J20 (APPSwe/Ind)mice [31] lead-
ing to the hypothesis that microglia are causing early synaptic damage.
We put forward an alternative hypothesis that the microglia are rather
removing spines and boutons damaged by the high levels of soluble
oligomeric Αβ in or near the plaques and that this may represent a
protective function, avoiding further damage to the dendrites and
axons affected and hence protecting network function. This is further
supported by the observation that as plaques grow synaptic loss is con-
centrated near to the plaques and the loss decreases further from
plaques [32,33].ts of rising amyloidβ levels on hippocampal synaptic transmission,
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cal to thosewe have previously reported at 4months, with no change in
miniature currents but a complete loss of spontaneous activity and an
increase in release probability of glutamate. Particularly at early stages,
the plaque load in terms of the percentage tissue coverage is very low
and so very few of the synapses recorded would be close to a plaque.
Moreover, the observation that the change in paired-pulse ratio is sim-
ilar despite a rising plaque load also suggests that the plaques them-
selves are unlikely to be causing this effect. Hence, this is presumably
the result of very low levels of soluble Αβ throughout the tissue. In-
creased release probability has been reported to be the physiological ef-
fect of Αβ release in wild type rats [5]. As the plaque load increases and
larger plaques start to appear, additional changes become evident. At
12 months, although the evoked release probability is still similarly af-
fected, being higher in the transgenic mice than the wild type mice,
there is also a reduction in the frequency of miniature EPSCs. The sim-
plest interpretations of loss of miniature frequency is either a loss of
functional synapses or a decreased release probability (see reference
34 for review). As we have demonstrated that release probability is in-
creased, this suggests that a loss of synapses is the likely explanation. In
and around the plaques soluble and insoluble Αβwill be in equilibrium
and with increased plaque coverage with age, at least some of the syn-
apses will be directly affected by the high local concentration of Αβ in
the close vicinity of a plaquewhich could lead to this loss. Note that, un-
like evoked currents,miniature synaptic currents can originate fromany
synapse in the tissue and hence some will be physically near plaques.
The increasing effect as the plaque load rises, supports this hypothesis.
This is again consistent with the observation that synaptic loss occurs
with increased plaque load but that the loss is inversely proportional
to distance from a plaque [32]. Consistentwith this notion, neuronal hy-
peractivity occurs proximal to plaques and decreases more distal to
plaques within a radius of 60 μm [35].
It is notable that the decrease in frequency of miniature EPSCs ob-
served at 12 months coincides with the increase in microglial number
and activation but that it does not decrease any further by 18 months.
This is consistentwith the plaque load and indeed themicroglial density
largely plateauing by 14months. The very effectivemicroglial prolifera-
tion and subsequent phagocytic phenotype, associated with strong up-
regulation of microglial genes such as Trem2 that we have previously
reported at this age [10],may be one of the reasonswhy the progression
of Alzheimer's pathology to neuroﬁbrillary tangles and neurodegenera-
tion does not go further in these mice.
The biphasic change in LTP induced by amild tetanic stimulus at the
early stages of pathology in Αβmice is of interest. At 2 months of age,
prior to detection of plaques and when LTP is enhanced in the Αβ
mice, Aβ is certainly present, albeit at low levels [10,16]. By 4 months
of age, when the ﬁrst plaques are evident, Aβ levels are at least
10-fold higher than at 2 months. At this stage the opposite effect is ob-
served with magnitude of tetanus-induced LTP much reduced com-
pared to wild types. This LTP deﬁcit was maintained both at 12 and
18 months of age. The biphasic pattern of change may reﬂect the in-
creasing glutamate release probability which we have previously
shown is greater at 4 months than at 2 months of age. If glutamate
were more readily released during conditioning, the initial outcome
may be a greater calcium inﬂux through NMDA receptors and thus a
larger magnitude LTP. However, as levels rise by 4 months and release
probability increases further, depletion of the readily-releasable pool
of synaptic vesicles during the ﬁrst pulses of the conditioning train
may result in a failure to release transmitter as the train continues,
thus impairing LTP. Alternatively, the higher levels of Aβ may have
other effects, interacting with NMDA receptors directly and impeding
LTP (reviewed in reference 36). Moreover, Aβ is itself proposed to be re-
leased in an activity-dependentmanner [37–39] and hence, as its levels
rise, resulting in increased release probability, this could lead to a posi-
tive feedback.Please cite this article as: E. Medawar, T.A. Benway, W. Liu, et al., Effec
microglial response and cogn..., EBioMedicine, https://doi.org/10.1016/j.ebIn concertwith (or alternatively to) the direct physiological effects of
low levels of Aβ, the early increase in LTPmagnitudewe report could be
an interaction with the mutant presenilin 1. Expression of both normal
and mutant presenilin 1 has direct effects on synaptic transmission and
plasticity. For example, the A246Emutation leads to increased LTPmag-
nitude at young ages [40,41], while the L286V mutation increases LTP
magnitude at young ages but decreases at older (14 month) ages [42].
Here we show that the M146V mutation increases the magnitude of
LTP at 24 months of age, which could be the underlying mechanism of
the initial increased LTP observed in the TASTPM, until the later Aβ ef-
fects become dominant, decrementing the LTP.
Again, cytokines released as part of the immune response to raised
Aβ levels and plaque deposition could offer an additional route for the
altered synaptic transmission and plasticity that we observe. It has
long been established that cytokines can modulate synaptic plasticity
[43] and indeed learning and memory [44].
Interestingly when theta-burst stimulation was used for induction,
during which the readily-releasable pool would have a chance to re-
plenish, there was no signiﬁcant deﬁcit in LTP at 4 months. However,
under these conditions at 2 months, we see a decrease in paired-pulse
ratio following induction of LTP that remains throughout the experi-
ment, indicating an increase in release probability. As outlined above,
the physiological effect of Aβ is to increase release probability, and so
this suggests that the theta rhythm itself may be causing local release
of Αβ at the stimulated synapses. Despite this apparent presynaptic
increase in transmission, the magnitude of LTP remains unaltered,
raising the possibility of a postsynaptic decrease balancing this effect.
However, when TEA was applied to slices, resulting in a wide-spread
depolarisation and thus release of all neurotransmitter vesicles (excit-
atory, inhibitory and modulatory), LTP was induced similarly to wild
types conﬁrming that some forms of long-term plasticity remain intact.
In our hands, the locus of expression of LTP, induced by tetanus, tends to
have a presynaptic component in both genotypes, indicated by a change
in paired-pulse proﬁle following induction.
In this study, TASTPMmice showed nomeasurable cognitive deﬁcits
at any age, despite a substantial plaque load. There were, however, clear
differences in activity and anxiety related behaviours. The TASTPMmice
were slower to perform the T-maze task than the wild type mice or
failed to do so altogether. Furthermore, in other tests, decreased activity
and increased anxiety were evident. Although not speciﬁcally mea-
sured, the TASTPM mice are also more aggressive than wild type mice
[45].
The improved retention of learning in TASTPMmice, requiringno re-
peat training when the same mice were tested twice at 8 and
12 months, may appear counterintuitive. However, similar outcomes
in hippocampal learning have been reported in TASTPMmice at around
4months, using a contextual fear conditioning regime.Whilemicewere
unimpaired in learning the task in these previous reports, they failed to
extinguish their learnt fear behaviour when conditioning was reversed
[13,14,46]. In the present study, the difference was additionally noted,
with the TASTPM mice also making more correct choices than the
wild type mice when a delay between runs was introduced.
The subtlety of the cognitive changes reported here in the TASTPM
mouse, even at stages where a heavy plaque load is present, is consis-
tent with previous ﬁndings [13–15,46]. Even when other Αβ models
are considered, cognitive deﬁcits are limited and, where present, it is
unclear how they truly translate to the human disease (for reviews,
see references 47, 48).Moreover, this is consistentwith the human con-
dition, where, at the time of diagnosis, when cognitive deﬁcits are ﬁrst
being detected, there is already a substantial reduction in hippocampal
volume of up to 20% [49], whereas there is no apparent neuronal loss in
TASTPM mice. Furthermore, in humans, cognitive decline correlates
well with Tau PET markers and less with Aβ load [50]. Given that Αβ
mouse models are not a complete model of AD, i.e. lacking Tau tangle
formation and neurodegeneration, which more faithfully correlatets of rising amyloidβ levels on hippocampal synaptic transmission,
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clinical disease, when Αβ is ﬁrst deposited.
Herewe bring together the progression of pathology, microglia, syn-
aptic transmission and other functional changes in a preclinical mouse
model of AD. In a following paper we compare these results in mice
with only plaques and no neuroﬁbrillary tangles to a transgenic
mouse model of later stage dementia in which neuroﬁbrillary tangles
occur without plaques [51].
From the present studywe conclude that the earliest effects of Αβ on
synaptic transmission are probably due to very low levels of soluble Αβ
in the volume of the tissue, rather than being directly related to plaques.
At this early stage plaques are extremely small and sparse so that they
would impinge directly on very few synapses. However, while wide-
spread soluble Αβ may also inﬂuence early microglial changes these
may well be inﬂuenced by the earliest seeding of plaques or the release
of cytokines into the environment. Later changes most probably relate
to the increasing numbers of larger plaques with the cloud of high-
level soluble Αβ surrounding them impinging on a, still limited, but
much greater area. The direct effects of this localised high concentration
of soluble Αβ include loss of active synapses and activation of microglia,
likely involved in clearing damaged synapses near or within plaques via
phagocytosis and thus preventing wider damage to the affected axons
and dendrites. While seeding of new plaques seems to continue
throughout the development of plaque pathology, it is only once large
plaques are present that these latter changes occur. Moreover, the lack
of cognitive deﬁcits is similar to the human situation prior to the
build-up of neuroﬁbrillary tangles andneurodegeneration and thus sug-
gests that TASTPM represent a good model of the prodromal phase of
the disease. Thus, these phenotypes are likely to represent the early
stages in individuals who will go on to develop Alzheimer's disease.
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